Clash of the Thrombosis Titans: Clinical Controversies in Venous Thromboembolism

Nov 17, 2019 10:45am ‐ Nov 17, 2019 12:00pm

Credits: None available.

Standard: $35.00
Members: $25.00

DOACs Should Be First Line for Treatment of VTE in Cancer
10:45am - 12:00pm
Jean Connors

DOACs Should NOT Be First Line for Treatment of VTE in Cancer
10:45am - 12:00pm
Gary Raskob

VTE Prophylaxis Should Be Given to Most Cancer Patients Receiving Chemotherapy
10:45am - 12:00pm
Alok Khorana

VTE Prophylaxis Should NOT Be Given to Most Cancer Patients Receiving Chemotherapy
10:45am - 12:00pm
rachel rosovsky

Patients With Provoked VTE and Persistent Risk Factor Should Get Extended Anticoagulation
10:45am - 12:00pm
Samuel Goldhaber

Patients With Provoked VTE and Persistent Risk Factor Should NOT Get Extended Anticoagulation
10:45am - 12:00pm
Teresa Carmen

The Guidelines Are Wrong: High Risk Medical Patients Should Receive Extended VTE Prophylaxis
10:45am - 12:00pm
Alex Spyropoulos

Clash of the Thrombosis Titans: Clinical Controversies in Venous Thromboembolism - Panel Discussion
10:45am - 12:00pm
Panel Discussion

Credits: None available.

You must be logged in and own this session in order to post comments.